Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 12
Submit an article Journal homepage
70
Views
6
CrossRef citations to date
0
Altmetric
Theme: Thrombosis - Key Paper Evaluation

Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial

Fabio Angeli Section of Cardiology, Hospital Media Valle del Tevere, AUSL 2 dell’Umbria, Perugia, Italy. [email protected]; Section of Cardiology, Hospital Media Valle del Tevere, AUSL 2 dell’Umbria, Perugia, Italy. [email protected]
,
Paolo Verdecchia Department of Internal Medicine, Hospital of Assisi, Assisi, Italy; Department of Internal Medicine, Hospital of Assisi, Assisi, Italy
&
Gianpaolo Reboldi Department of Internal Medicine, University of Perugia, Perugia, Italy; Department of Internal Medicine, University of Perugia, Perugia, Italy
Pages 1467-1470 | Published online: 10 Jan 2014

References

  • Cushman WC, Evans GW, Byington RP et al.; ACCORD Study Group. Effects of intensive blood-pressure control in Type 2 diabetes mellitus. N. Engl. J. Med. 362(17), 1575–1585 (2010).
  • Gerstein HC, Miller ME, Byington RP et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med. 358(24), 2545–2559 (2008).
  • Ginsberg HN, Elam MB, Lovato LC et al.; ACCORD Study Group. Effects of combination lipid therapy in Type 2 diabetes mellitus. N. Engl. J. Med. 362(17), 1563–1574 (2010).
  • Mancia G, Laurent S, Agabiti-Rosei E et al.; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 27(11), 2121–2158 (2009).
  • Verdecchia P, Angeli F. [The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the weapons are ready]. Rev. Esp. Cardiol. 56(9), 843–847 (2003).
  • Barzilay JI, Howard AG, Evans GW et al. Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Diabetes Care 35(7), 1401–1405 (2012).
  • Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr. Res. Rev. 23(2), 247–269 (2010).
  • Verdecchia P, Angeli F, Reboldi G. New-onset diabetes, antihypertensive treatment, and outcome. Hypertension 50(3), 459–460 (2007).
  • Verdecchia P, Angeli F, Reboldi GP, Gattobigio R. New-onset diabetes in treated hypertensive patients. Curr. Hypertens. Rep. 7(3), 174–179 (2005).
  • Reboldi G, Gentile G, Angeli F, ­Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J. Hypertens. 29(7), 1253–1269 (2011).
  • Verdecchia P, Angeli F, Achilli P et al. Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? Curr. Opin. Cardiol. 22(4), 329–334 (2007).
  • Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr. Pharm. Des. 10(29), 3621–3637 (2004).
  • Reboldi G, Gentile G, Angeli F, ­Verdecchia P. Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. Expert Rev. Cardiovasc. Ther. 7(11), 1349–1361 (2009).
  • Reboldi G, Gentile G, Angeli F, Verdecchia P. Optimal therapy in hypertensive subjects with diabetes mellitus. Curr. Atheroscler. Rep. 13(2), 176–185 (2011).
  • Reboldi G, Gentile G, Manfreda VM, Angeli F, Verdecchia P. Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. Curr. Cardiol. Rep. 14(1), 89–96 (2012).
  • Reboldi G, Gentile G, Angeli F, ­Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with Type 2 diabetes: update after recent clinical trials. Vasc. Health Risk Manag. 5(1), 411–427 (2009).
  • Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive Type 2 diabetes mellitus: a summary of the ABCD trial. Nat. Clin. Pract. Nephrol. 3(8), 428–438 (2007).
  • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ 317, 703–713 (1998).
  • Cooper-DeHoff RM, Gong Y, Handberg EM et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 304(1), 61–68 (2010).
  • McBrien K, Rabi DM, Campbell N et al. Intensive and standard blood pressure targets in patients with Type 2 diabetes mellitus: systematic review and ­meta-analysis. Arch. Intern. Med. 6, 1–8 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.